An Injectable Engineered Cartilage Gel Improves Intervertebral Disc Repair in a Rat Nucleotomy Model
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24043146 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Basanta Bhujel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, College of Life Sciences, CHA University, Seongnam 13496, Republic of Korea. Hauptthemen laut MEDLINE: Intervertebral Disc Degeneration, Low Back Pain, Intervertebral Disc. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, Ministry for Health and Welfare Affairs.
Abstract (Originalsprache)
Lower back pain is a major problem caused by intervertebral disc degeneration. A common surgical procedure is lumbar partial discectomy (excision of the herniated disc causing nerve root compression), which results in further disc degeneration, severe lower back pain, and disability after discectomy. Thus, the development of disc regenerative therapies for patients who require lumbar partial discectomy is crucial. Here, we investigated the effectiveness of an engineered cartilage gel utilizing human fetal cartilage-derived progenitor cells (hFCPCs) on intervertebral disc repair in a rat tail nucleotomy model. Eight-week-old female Sprague-Dawley rats were randomized into three groups to undergo intradiscal injection of (1) cartilage gel, (2) hFCPCs, or (3) decellularized extracellular matrix (ECM) (n = 10/each group). The treatment materials were injected immediately after nucleotomy of the coccygeal discs. The coccygeal discs were removed six weeks after implantation for radiologic and histological analysis. Implantation of the cartilage gel promoted degenerative disc repair compared to hFCPCs or hFCPC-derived ECM by increasing the cellularity and matrix integrity, promoting reconstruction of nucleus pulposus, restoring disc hydration, and downregulating inflammatory cytokines and pain. Our results demonstrate that cartilage gel has higher therapeutic potential than its cellular or ECM component alone, and support further translation to large animal models and human subjects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Science, College of Life Sciences, CHA University, Seongnam 13496, Republic of Korea.
- ATEMs Inc., Seoul 02447, Republic of Korea.
- Department of Neurosurgery, Kyung Hee University, Dongdaemun-gu, Seoul 02447, Republic of Korea.
- Wake Forest Institute of Regenerative Medicine, School of Medicine, Wake Forest University, Winston Salem, NC 27101, USA.
- Department of Biomedical Sciences, Inha University College of Medicine, Incheon 22212, Republic of Korea.
- Department of Neurosurgery, CHA Bundang Medical Center, School of Medicine, CHA University, Seongnam 13496, Republic of Korea.
ORCID-Profile: Inbo Han
Förderung
- NIEHS NIH HHS
- Ministry for Health and Welfare Affairs
Zitieren
APA
Bhujel, B., Yang, S. S., Kim, H. R., Kim, S. B., Min, B. H., Choi, B. H., & Han, I. (2023). An Injectable Engineered Cartilage Gel Improves Intervertebral Disc Repair in a Rat Nucleotomy Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043146
Vancouver
Bhujel B, Yang SS, Kim HR, Kim SB, Min BH, Choi BH, et al. An Injectable Engineered Cartilage Gel Improves Intervertebral Disc Repair in a Rat Nucleotomy Model. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043146
BibTeX
@article{Bhujel2023,
author = {Bhujel, Basanta and Yang, Soon Shim and Kim, Hwal Ran and Kim, Sung Bum and Min, Byoung-Hyun and Choi, Byung Hyune and Han, Inbo},
title = {An Injectable Engineered Cartilage Gel Improves Intervertebral Disc Repair in a Rat Nucleotomy Model},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24043146}
}
EUVIMED